Wiadomości Eulerpool Biomea Fusion

Biomea Fusion Wiadomości o akcjach

Biomea Fusion jest obserwowany przez wielu dziennikarzy i inwestorów na całym świecie. Najnowsze wiadomości Biomea Fusion przedstawiamy tutaj.

• 9 stycznia ·

  Yahoo
  3 US Penny Stocks With Market Caps Up To $2B
• 7 stycznia ·

  Yahoo
  Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
• 6 stycznia ·

  Yahoo
  Here’s Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10
• 6 stycznia ·

  Yahoo
  Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 17 grudnia ·

  Yahoo
  Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
• 17 grudnia ·

  Yahoo
  Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes
• 17 grudnia ·

  Yahoo
  Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
• 9 grudnia ·

  Yahoo
  Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
• 6 grudnia ·

  Yahoo
  Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia
• 18 listopada ·

  Yahoo
  Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)